In COVID-19 with hypoxemia, 12 vs. 6 mg/d of dexamethasone did not increase days alive without life support.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 35226531.
- Also identified by DOI 10.7326/J22-0001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Munch MW, Myatra SN, Vijayaraghavan BK, et al. <b>Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial.</b> JAMA. 2021;326:1807-17. 34673895.
Medical subject headings
- COVID-19 Drug Treatment